Table: Phoenixbio -2023/24 parent results
May 15 (Reuters)-
Phoenixbio Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.72 2.12
(-19.2 pct) (+60.3 pct)
Operating loss 97 mln 410 mln
Recurring loss 64 mln 413 mln
Net loss 83 mln 397 mln
EPS loss 21.97 yen 116.92 yen
EPS Diluted 78.32 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Phoenixbio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T